Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05687344 · ClinicalTrials.gov registry record · Phase 3
Intensive Postpartum Antihypertensive Treatment
A Phase 3 study of Hypertensive Disorder of Pregnancy, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- Phase 3
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05687344 is a Phase 3 study of Hypertensive Disorder of Pregnancy that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 60 participants, below the 2,692-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05687344, a Phase 3 study of Hypertensive Disorder of Pregnancy, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of cardiovascular disease risk.
Conditions Studied
Interventions
- DRUG Nifedipine ER
Study Locations (1)
Wisconsin
- Froedtert Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05687344
The ClinicalTrials.gov registry entry for NCT05687344 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,692-participant average among 8 other Hypertensive Disorder of Pregnancy trials with a reported enrollment target (98% lower). The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertensive Disorder of Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine ER is the first listed.
NCT05687344 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05687344 about?
NCT05687344 is a clinical study titled "Intensive Postpartum Antihypertensive Treatment". The long-term goal of our work is to evaluate the effect of intensive postpartum blood pressure control on maternal cardiovascular health, risk of chronic hypertension, and reversal of vascular dysfunction generated by hypertensive disorders of pregnancy, thus attenuating the lifelong trajectory of ...
What is the current status of trial NCT05687344?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 60 participants. The study started on 2023-09-01. Estimated completion is 2026-03.
What conditions does trial NCT05687344 study?
This clinical trial studies the following conditions: Hypertensive Disorder of Pregnancy.
What interventions are being tested in trial NCT05687344?
The interventions under investigation include: Nifedipine ER (DRUG).
Who is sponsoring clinical trial NCT05687344?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05687344 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertensive Disorder of Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Treatment With Aspirin After Preeclampsia: TAP Trial
RECRUITING · Phase 4
-
HOPE-BP 2.0: Evaluating the Optimal Duration of Postpartum Remote Blood Pressure Monitoring
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
The Preeclampsia Registry
RECRUITING
-
Platelets in Pregnancy
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.